MRI & PET imaging in malignant brain tumors

Japanese Journal of Neurosurgery

Volumn 15, Issue 10, 2006, Pages 672-679

  Nakamura, Hideo ^a   Kuratsu, Jun Ichi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Brain tumor; MRI diffusion imaging; MRI perfusion imaging; PET

Indexed keywords

FLUORODEOXYGLUCOSE;

BRAIN ABSCESS; CLINICAL FEATURE; DIFFUSION WEIGHTED IMAGING; GLIOBLASTOMA; HUMAN; INTERMETHOD COMPARISON; PERFUSION WEIGHTED IMAGING; PREOPERATIVE EVALUATION; REVIEW; TUMOR CELL; TUMOR DIAGNOSIS; TUMOR GROWTH;

EID: 33750321028     PISSN: 0917950X     EISSN: None     Source Type: Journal    
DOI: 10.7887/jcns.15.672     Document Type: Review

References (12)

1. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, Harsh GR, Cosgrove GR, Halpern EF, Hochberg FH: Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings. Radiology 191: 41-51, 1994.
2. 18F-FDG PET. Eur J Nucl Med Mol Imaging 32: 52-59, 2005.
3. Lev MH, Ozsunar Y, Henson JW, Rasheed AA, Barest GD, Harsh GR 4th, Fitzek MM, Chiocca EA, Rabinov JD, Csavoy AN, Rosen BR, Hochberg FH, Schaefer PW, Gonzalez RG: Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: Confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 25: 214-221, 2004.
4. Murakami R, Sugahara T, Nakamura H, Hirai T, Kitajima M, Hayashida Y, Baba Y, Oya N, Kuratsu J, Yamashita Y: Predictive value of pretreatment quantitative diffusion-weighted MR imaging in patients with malignant supratentorial astrocytomas treated with postoperative radiation therapy. Radiology: 2006 (in press).
5. Nariai T, Tanaka Y, Wakimoto H, Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg 103: 498-507, 2005.
6. Okamoto K, Ito J, Ishikawa K, Sakai K, Tokiguchi S: Diffusion-weighted echo-planar MR imaging in differential diagnosis of brain tumors and tumor-like conditions. Eur Radiol 10: 1342-1350, 2000.
7. Rachinger W, Goetz C, Popperl G, Gildehaus FJ, Kreth FW, Holtmannspotter M, Herms J, Koch W, Tatsch K, Tonn JC: Positron emission tomography with O-(2-[18F] fluoroethyl)-1-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Neurosurgery 57: 505-511, 2005.
8. Ribom D, Smits A: Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas. Neurol Res 27: 516-521, 2005.
9. Roelcke U, Leenders KL: Positron emission tomography in patients with primary CNS lymphomas. J Neurooncol 43: 231-236, 1999.
10. Schaefer PW, Grant PE, Gonzalez RG: Diffusion-weighted MR imaging of the brain. Radiology 217: 331-345, 2000.
11. Sugahara T, Korogi Y, Kochi M, Ikushima I, Shigematu Y, Hirai T, Okuda T, Liang L, Ge Y, Komohara Y, Ushio Y, Takahashi M: Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9: 53-60, 1999.
12. Sugahara T, Korogi Y, Kochi M, Ikushima I, Hirai T, Okuda T, Shigematsu Y, Liang L, Ge Y, Ushio Y, Takahashi M: Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 171: 1479-1486, 1998.